Telesis Bio, Inc. (TBIO)

NASDAQ: TBIO · IEX Real-Time Price · USD
-0.07 (-3.65%)
At close: May 26, 2023, 4:00 PM
+0.07 (3.78%)
After-hours: May 26, 2023, 6:37 PM EDT

Total Valuation

Telesis Bio has a market cap or net worth of $1.11 billion. The enterprise value is $1.12 billion.

Market Cap 1.11B
Enterprise Value 1.12B

Important Dates

The last earnings date was Thursday, May 11, 2023, after market close.

Earnings Date May 11, 2023
Ex-Dividend Date n/a

Share Statistics

Telesis Bio has 29.61 million shares outstanding. The number of shares has increased by 1.13% in one year.

Shares Outstanding 29.61M
Shares Change (YoY) +1.13%
Shares Change (QoQ) +0.33%
Owned by Insiders (%) 37.39%
Owned by Institutions (%) 43.15%
Float 8.85M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 39.35
Forward PS 16.56
PB Ratio 30.21
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 39.69
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.82, with a Debt / Equity ratio of 1.14.

Current Ratio 3.82
Quick Ratio 3.39
Debt / Equity 1.14
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -92.20% and return on invested capital (ROIC) is -77.50%.

Return on Equity (ROE) -92.20%
Return on Assets (ROA) -52.10%
Return on Capital (ROIC) -77.50%
Revenue Per Employee $126,076
Profits Per Employee -$208,054
Employee Count 223
Asset Turnover 0.32
Inventory Turnover 4.88


In the past 12 months, Telesis Bio has paid $21,000 in taxes.

Income Tax 21,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -55.31% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -55.31%
50-Day Moving Average 2.55
200-Day Moving Average 1.94
Average Volume (30 Days) 2,912,959

Short Selling Information

The latest short interest is 225,986, so 0.76% of the outstanding shares have been sold short.

Short Interest 225,986
Short Previous Month 182,749
Short % of Shares Out 0.76%
Short % of Float 2.55%
Short Ratio (days to cover) 3.04

Income Statement

In the last 12 months, Telesis Bio had revenue of $28.12 million and -$46.40 million in losses. Loss per share was -$1.57.

Revenue 28.12M
Gross Profit 16.33M
Operating Income -44.66M
Pretax Income -46.38M
Net Income -46.40M
EBITDA -41.82M
EBIT -45.25M
Loss Per Share -$1.57
Full Income Statement

Balance Sheet

The company has $32.24 million in cash and $41.72 million in debt, giving a net cash position of -$9.47 million or -$0.32 per share.

Cash & Cash Equivalents 32.24M
Total Debt 41.72M
Net Cash -9.47M
Net Cash Per Share -$0.32
Equity / Book Value 36.62M
Book Value Per Share 1.24
Working Capital 31.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$44.26 million and capital expenditures -$4.48 million, giving a free cash flow of -$48.74 million.

Operating Cash Flow -44.26M
Capital Expenditures -4.48M
Free Cash Flow -48.74M
FCF Per Share -$1.64
Full Cash Flow Statement


Gross margin is 58.08%, with operating and profit margins of -158.83% and -165.02%.

Gross Margin 58.08%
Operating Margin -158.83%
Pretax Margin -164.95%
Profit Margin -165.02%
EBITDA Margin -148.76%
EBIT Margin -160.93%
FCF Margin -173.36%

Dividends & Yields

Telesis Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -4.19%
FCF Yield -4.41%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -1.13%
Shareholder Yield -1.13%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a